Brightree

brightree.com

Brightree
At Brightree, we believe in building innovative technology solutions and providing services to the post-acute healthcare industry that help to enhance clinical and business performance.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MARINUS PHARMACEUTICALS EARNS RARE PEDIATRIC DISEASE DESIGNATION FROM FDA FOR GANAXOLONE TREATING CDKL5 DEFICIENCY DISORDER (CDD)

Marinus Pharmaceuticals | July 31, 2020

news image

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for the company’s product candidate ganaxolone for the treatment of CDKL5 deficiency disorder (CDD), a rare refractory form of pediatric epilepsy. “We are pleased that ganaxolone has received Rare Pediatric Dis...

Read More

ELI LILLY, SITRYX SIGN POTENTIAL $880M DEAL TO DEVELOP IMMUNOMETABOLIC MEDICINES

Pharmaceutical Business review - | April 01, 2020

news image

Eli Lilly has entered into a potential $880m research deal with Sitryx to discover and develop new immunometabolic medicines. Under an exclusive global licensing and research collaboration, the companies will involve in the assessment of up to four novel preclinical targets detected by Sitryx. The new targets may help develop potential new medicines for autoimmune diseases. Lilly immunology vice president Dr Ajay Nirula said: “As Lilly seeks to develop new and unique medicines for people s...

Read More

RX SAVINGS SOLUTIONS ANNOUNCES EXPANSION OF PHARMACY TRANSPARENCY OFFERING TO MID-MARKET ORGANIZATIONS

Prnewswire | May 27, 2020

news image

Rx Savings Solutions announced today its entrance into the mid-market segment with the expansion of their personalized prescription drug transparency program to midsize organizations. With this comprehensive solution driven by more than 29,000 clinical recommendations, more benefit leaders of all sizes can provide a valuable resource for members to engage with personalized savings options. As pharmacy continues to be the most predictable and repeated spend in healthcare, Rx Savings Solutions aim...

Read More

Business Insights

LONG ISLAND UNIVERSITY EXTENDS PARTNERSHIP WITH DASSAULT SYSTÈMES TO INNOVATION AND RESEARCH IN LIFE SCIENCES

Long Island University | March 23, 2022

news image

Long Island University announced a new research and innovation partnership with Dassault Systèmes in life sciences. The partnership will focus on research with high societal impact to advance the fields of pharmaceutical sciences, precision medicine and health care in the digital age. Research includes precision medicine using "Virtual Twins," or exact digital models of human anatomy being developed by LIU and Dassault Systèmes; pandemic preparedness and th...

Read More
news image

MARINUS PHARMACEUTICALS EARNS RARE PEDIATRIC DISEASE DESIGNATION FROM FDA FOR GANAXOLONE TREATING CDKL5 DEFICIENCY DISORDER (CDD)

Marinus Pharmaceuticals | July 31, 2020

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for the company’s product candidate ganaxolone for the treatment of CDKL5 deficiency disorder (CDD), a rare refractory form of pediatric epilepsy. “We are pleased that ganaxolone has received Rare Pediatric Dis...

Read More
news image

ELI LILLY, SITRYX SIGN POTENTIAL $880M DEAL TO DEVELOP IMMUNOMETABOLIC MEDICINES

Pharmaceutical Business review - | April 01, 2020

Eli Lilly has entered into a potential $880m research deal with Sitryx to discover and develop new immunometabolic medicines. Under an exclusive global licensing and research collaboration, the companies will involve in the assessment of up to four novel preclinical targets detected by Sitryx. The new targets may help develop potential new medicines for autoimmune diseases. Lilly immunology vice president Dr Ajay Nirula said: “As Lilly seeks to develop new and unique medicines for people s...

Read More
news image

RX SAVINGS SOLUTIONS ANNOUNCES EXPANSION OF PHARMACY TRANSPARENCY OFFERING TO MID-MARKET ORGANIZATIONS

Prnewswire | May 27, 2020

Rx Savings Solutions announced today its entrance into the mid-market segment with the expansion of their personalized prescription drug transparency program to midsize organizations. With this comprehensive solution driven by more than 29,000 clinical recommendations, more benefit leaders of all sizes can provide a valuable resource for members to engage with personalized savings options. As pharmacy continues to be the most predictable and repeated spend in healthcare, Rx Savings Solutions aim...

Read More
news image

Business Insights

LONG ISLAND UNIVERSITY EXTENDS PARTNERSHIP WITH DASSAULT SYSTÈMES TO INNOVATION AND RESEARCH IN LIFE SCIENCES

Long Island University | March 23, 2022

Long Island University announced a new research and innovation partnership with Dassault Systèmes in life sciences. The partnership will focus on research with high societal impact to advance the fields of pharmaceutical sciences, precision medicine and health care in the digital age. Research includes precision medicine using "Virtual Twins," or exact digital models of human anatomy being developed by LIU and Dassault Systèmes; pandemic preparedness and th...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us